Preliminary program

Thursday, October 31, 2019

18:00 Registration Opens
19:00 Welcome Reception

 

Friday, November 1, 2019

Hall A Hall B Posters
08:30 Plenary
09:30 Plenary
10:30 Coffee break Guided Posters
11:00 HTN- The classic:
a. Diagnosis, definitions, measuring methodsb. Initial work up and whyc. Treatment- choosing wiselyd. Interactive examples
DIABETES – theme 1: 

a. Classification, presentations

b. Diagnostic criteria and pitfalls

c. Algorithms of therapy

d. Interactive Cases

12:00 HTN- The ongoing journey:

a. How to empower the patients interacting challenges

1. Smoking, eating and drinking – how to celebrate health?
2. Anxiety, stress and HTN

b. Intensive sport

c. Nailing the moving target

d. Follow up- structured

1. Office unattended BPM
2.Home BPM
3.ABPM- to who and how to read the results

e. Interactive examples

DIABETES – theme 2: 

a. when treatment algorithms fail

b. combination therapies (oral agents)

c. Combination therapies (oral and injectables)

d. Aging diabetic

e. Interactive cases

13:00 Lunch
14:00 DIABETES – theme 1: 

a. Classification, presentations

b. Diagnostic criteria and pitfalls

c. Algorithms of therapy

d. Interactive Cases

 LIPIDS- Primary prevention :

a. Guidelines

b. Who (not) to treat

c. Targets and strategies

d. Challenging patients (women children elderly)

15:00 DIABETES – theme 2: 

a. when treatment algorithms fail

b. combination therapies (oral agents)

c. Combination therapies (oral and injectables)

d. Aging diabetic

e. Interactive cases

 

LIPIDS- Secondary prevention:

a. Guidelines

b. Who (not) to treat

c. Targets and strategies

d. Challenging Patients (compliance Triglycerides HDL-c)

16:00 Coffee break Guided Posters
16:30  LIPIDS- Primary prevention :

a. Guidelines

b. Who (not) to treat

c. Targets and strategies

d. Challenging patients (women children elderly)

 

HTN- The classic:
a. Diagnosis, definitions, measuring methodsb. Initial work up and whyc. Treatment- choosing wiselyd. Interactive examples
17:30 LIPIDS- Secondary prevention:

a. Guidelines

b. Who (not) to treat

c. Targets and strategies

d. Challenging Patients (compliance Triglycerides HDL-c)

HTN- The ongoing journey:

a. How to empower the patients interacting challenges

1. Smoking, eating and drinking – how to
celebrate health?
2. Anxiety, stress and HTN

b. Intensive sport

c. Nailing the moving target

d. Follow up- structured

1. Office unattended BPM

2.Home BPM

3.ABPM- to who and how to read the results

e. Interactive examples

 

      Saturday, November 2, 2019

Hall A Hall B Posters
08:30 HTN- Complex patients:

a. High risk

b. Polypharmacopeia

c. Drug induced HTN, including chemotherapy

d. Compliance

e. Resistant

f. Pregnancy HTN

g. OH-SH
h. Interactive examples

DIABETES – theme 3: 
a. diabetic complications micro and macro (also NAFLD)b. intensifying therapy while avoiding hypoglycemiac. does intensive therapy prevent primary and secondaryd. interactive cases
09:30 HTN- Secondary HTN:
a. When to suspectb. Targeted evaluation1. Neuroendocrine HTN2. Reno-vascular

3. OSA

c. Interactive examples

DIABETES – theme 4:
a. devices, CGM and pumpsb. artificial/bionic pancreasc. new forms of therapyd. interactive cases
10:30 Coffee break  Guided Posters
11:00 DIABETES – theme 3: 
a. diabetic complications micro and macro (also NAFLD)b. intensifying therapy while avoiding hypoglycemiac. does intensive therapy prevent primary and secondaryd. interactive cases
LIPIDS- Difficult cases – Familial Hypercholesterolemia :

a. Guidelines

b. Screening

c. Targets and strategies

d. Challenging cases (Children genetic testing homozygous FH)

 

12:00 DIABETES – theme 4:
a. devices, CGM and pumpsb. artificial/bionic pancreasc. new forms of therapyd. interactive cases
LIPIDS- New developments :
a. Diagnosisb. Treatmentc. Costs vs benefitd. Role of primary care physician
13:00 Lunch Guided Posters
14:00 LIPIDS- Difficult cases – Familial Hypercholesterolemia:

a. Guidelines

b. Screening

c. Targets and strategies

d. Challenging cases (Children genetic testing homozygous FH)

HTN- Complex patients:

a. High risk

b. Polypharmacopeia

c. Drug induced HTN, including chemotherapy

d. Compliance

e. Resistant

f. Pregnancy HTN

g. OH-SH
h. Interactive examples

15:00 LIPIDS- New developments:
a. Diagnosisb. Treatmentc. Costs vs benefitd. Role of primary care physician
HTN- Secondary HTN:
a. When to suspectb. Targeted evaluation1. Neuroendocrine HTN2. Reno-vascular

3. OSA

c. Interactive examples

 

16:00 Coffee break
16:30 Motivational talks
17:30 Motivational talks

 

sunday, November 3, 2019

Hall A Hall B Posters
08:30 Meet the Experts Meet the Experts
09:30 Meet the Experts Meet the Experts
10:30 Coffee break
Keep Me Updated